IONIS PHARMACEUT reported $159.77M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Agios Pharmaceuticals AGIO:US USD 3.52M 2.07M
Alnylam Pharmaceuticals ALNY:US USD 264.31M 39.49M
Arrowhead Research ARWR:US USD 31.58M 837K
Astellas Pharma 4503:JP JPY 380.39B 1.4B
Biocryst Pharmaceuticals BCRX:US USD 75.83M 10.3M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Bluebird Bio BLUE:US USD 71K 1.45M
Esperion Therapeutics ESPR:US USD 18.98M 139K
Exelixis EXEL:US USD 411.74M 7.69M
Halozyme Therapeutics HALO:US USD 208.98M 56.61M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Mirati Therapeutics MRTX:US USD 5.43M 69K
Moderna Inc MRNA:US USD 3.36B 1.38B
Nektar Therapeutics NKTR:US USD 23.62M 2.04M
Neurocrine Biosciences NBIX:US USD 387.9M 9.7M
Novartis NOVN:VX USD 12.84B 243M
Pfizer PFE:US USD 24.29B 1.65B
Ptc Therapeutics PTCT:US USD 217.13M 51.6M
Regeneron Pharmaceuticals REGN:US USD 2.94B 79M
Roche Holding ROG:VX CHF 32.3B 207M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
Ultragenyx Pharmaceutical RARE:US USD 90.7M 1.36M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M